Efficacy and Safety of Setmelanotide, a Melanocortin-4 Receptor Agonist, for Obese Patients: A Systematic Review and Meta-Analysis

Simple item page
dc.contributor.authorBárbara Ferraz Barbosa
dc.contributor.authorFrancisco Cézar Aquino de Moraes
dc.contributor.authorCamila Bordignon Barbosa
dc.contributor.authorPlínio Takashi Karubi Palavicini Santos
dc.contributor.authorIzael Pereira da Silva
dc.contributor.authorBruno Araujo Alves da Silva
dc.contributor.authorJamile Cristine Marques Barros
dc.contributor.authorRommel Mário Rodríguez Burbano
dc.contributor.authorNey Pereira Carneiro dos Santos
dc.contributor.authorMarianne Rodrigues Fernandes
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T21:02:43Z
dc.date.available2026-03-22T21:02:43Z
dc.date.issued2023
dc.descriptionCitaciones: 25
dc.description.abstractOur results support the use of setmelanotide in treating severe obesity.
dc.identifier.doi10.3390/jpm13101460
dc.identifier.urihttps://doi.org/10.3390/jpm13101460
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/85601
dc.language.isoen
dc.publisherMultidisciplinary Digital Publishing Institute
dc.relation.ispartofJournal of Personalized Medicine
dc.sourceUniversidad De Aquino Bolivia
dc.subjectMedicine
dc.subjectMelanocortin 4 receptor
dc.subjectInternal medicine
dc.subjectObesity
dc.subjectWeight loss
dc.subjectAdverse effect
dc.subjectMeta-analysis
dc.subjectRandomized controlled trial
dc.subjectGastroenterology
dc.titleEfficacy and Safety of Setmelanotide, a Melanocortin-4 Receptor Agonist, for Obese Patients: A Systematic Review and Meta-Analysis
dc.typereview

Files

Collections

Artículo Científico Publicado